Diasorin SpA (STU:34D) 3-Month Share Buyback Ratio: 1.65% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:34D Diasorin SpA STU:34D
80 GF Score
Price €74.06
GF Value €90.78
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Diasorin SpA 3-Month Share Buyback Ratio?

Diasorin SpA STU:34D +0.95% 80 3-Month Share Buyback Ratio is 1.65 as of Jun. 2026. GuruFocus rates STU:34D with a GF Score™ of 80/100 and a GF Value™ of €90.78 (Modestly Undervalued). The stock has 8 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

STU:34D
80GF Score
Diasorin SpA STU:34D
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 1.65 mean?
Diasorin SpA (STU:34D) has a 3-Month Share Buyback Ratio of 1.65 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Diasorin SpA and its competitors.
Is Diasorin SpA's 3-Month Share Buyback Ratio too high?
Diasorin SpA's current 3-Month Share Buyback Ratio is 1.65. Overall, Diasorin SpA has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's 3-Month Share Buyback Ratio compare to TMO and DHR?
Diasorin SpA's 3-Month Share Buyback Ratio of 1.65 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Diagnostics & Research company?
A good 3-Month Share Buyback Ratio depends on the Medical Diagnostics & Research industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Diasorin SpA and its competitors. Diasorin SpA's current 3-Month Share Buyback Ratio is 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (STU:34D) is currently considered Modestly Undervalued. The stock's GF Value™ is €90.78, compared to a current price of €74.06 — trading 18.4% below its estimated fair value. The current 3-Month Share Buyback Ratio is 1.65. Diasorin SpA's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Diasorin SpA (STU:34D), the current 3-Month Share Buyback Ratio is 1.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diasorin SpA (STU:34D) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €74.06 is trading 18.4% below its estimated GF Value™ of €90.78. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for STU:34D:

  • 3-Month Share Buyback Ratio: 1.65
  • GF Value™: €90.78 vs. price of €74.06 (18.4% below fair value)
  • GF Score™: 80/100 with 8 warning signs

No single metric tells the full story. See the STU:34D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
80GF Score

Get the complete analysis for STU:34D

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.06
Price
€90.78
GF Value